Agilon Health (NYSE:AGL) Reaches New 52-Week High – Here’s Why

Agilon Health, Inc. (NYSE:AGL) hit a new 52-week high on Thursday . The stock traded as high as $109.49 and last traded at $102.08, with a volume of 295802 shares changing hands. The stock had previously closed at $102.16.

Analyst Upgrades and Downgrades

AGL has been the subject of several research reports. Robert W. Baird increased their price objective on Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Benchmark reissued a “buy” rating and set a $95.00 price objective (up from $13.00) on shares of Agilon Health in a report on Thursday, May 21st. Weiss Ratings lowered Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 27th. Jefferies Financial Group raised Agilon Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $27.50 to $48.00 in a report on Thursday, May 7th. Finally, Wells Fargo & Company reissued an “overweight” rating and set a $72.00 price objective (up from $37.50) on shares of Agilon Health in a report on Friday, May 8th. Five investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Agilon Health currently has an average rating of “Hold” and an average price target of $58.73.

Agilon Health Stock Down 0.1%

The stock has a fifty day moving average price of $52.96 and a 200 day moving average price of $29.40. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a market capitalization of $1.70 billion, a P/E ratio of -4.73 and a beta of 3.02.

Agilon Health (NYSE:AGL) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.38 billion. On average, research analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current year.

Hedge Funds Weigh In On Agilon Health

A number of large investors have recently made changes to their positions in the stock. Alpine Global Management LLC bought a new position in shares of Agilon Health in the fourth quarter worth $84,000. Invesco Ltd. boosted its holdings in shares of Agilon Health by 30.7% in the fourth quarter. Invesco Ltd. now owns 1,004,266 shares of the company’s stock worth $692,000 after acquiring an additional 235,951 shares during the period. Mercer Global Advisors Inc. ADV purchased a new stake in shares of Agilon Health in the fourth quarter worth $86,000. Numerai GP LLC raised its position in shares of Agilon Health by 207.3% in the fourth quarter. Numerai GP LLC now owns 1,228,071 shares of the company’s stock worth $846,000 after buying an additional 828,472 shares in the last quarter. Finally, Odyssean LLC purchased a new stake in shares of Agilon Health in the fourth quarter worth $96,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.